No one suspected a 50 year old kidney drug called spironolactone might hold the key to a new generation of herpesvirus drugs.
University of Utah researchers hoped their new assay might uncover a new way to treat EBV infections – but they were shocked at what it turned up. How could a 50 year old kidney drug called Spironolactone have anything to do with EBV?
Four years later they knew how – and the possibility for a more effective drug to treat herpesvirus infections was borne.
The moral to this story – you never know where an answer may come from. It could even be sitting on an aisle in your pharmacy.
Find out more in a Simmaron Research Foundation sponsored blog:
Don't Miss Another Blog!
Like this blog?
Make sure you don’t miss another one by registering for our free ME/CFS and Fibromyalgia blogs here...
THE ME/CFS and FM CORONAVIRUS VACCINATION SIDE EFFECTS POLL
Tell us how your coronavirus vaccination went and find out how other people with ME/CFS and/or FM fared with their coronavirus vaccination in Health Rising’s Coronavirus Vaccine Side Effects Poll.
I have been wishing that they would do this very thing for Clonidine. Clonidine helps with my pain, but gives me nightmares, and dries me out terribly, which I don’t need with Sjögren’s in my family. I tried another centrally acting sympatholytic by the trade name of Intuniv, which actually made my pain much worse, so it’s not just the class of drug that helps. I may try to email the team that did this to see if they will do the same for Clonidine.
Have you looked into Dexamitonidine infusions? Expensive but better side effect profile
The Simmaron Research link no longer works. Any idea why?
Problems with creating a new website. Hopefully it will be up soon.
Hey Cort, Just a heads up that we still can’t find the article about Spironolactone talked about on this page via the link or by using the search bar.
Hey Cort! I wasn’t sure where to put this so you might see it but new study shows EBV activation with Long Haulers. “Evidence of Epstein Barr Virus Reactivation in Long COVID Patients
A study published on June 17th 2021 shows that the COVID 30% of the long-haul patients have EBV reactivation. Let’s review the study and the evidence presented.”
Hope I’m able to post the study links: Reference to the study
https://www.ncbi.nlm.nih.gov/pmc/arti…
Other studies supporting the evidence of EBV in COVID long-haul:
https://pubmed.ncbi.nlm.nih.gov/28956…
https://pubmed.ncbi.nlm.nih.gov/2987786/
https://pubmed.ncbi.nlm.nih.gov/23127…